F FOSRENOL
Live / Registered — Registered and renewed (as of 22 Oct 2025)
What this means for you
Registered since 26 Jul 2005. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 26 Jul 2025).
Record
- Serial number
- 78270561
- Registration number
- 2978995
- Mark type
- Design + words
- Filed
- 03 Jul 2003
- Published for opposition
- 18 May 2004
- Registered
- 26 Jul 2005
- Next maintenance due
- 26 Jul 2025
- Attorney of record
- Karl M. Zielaznicki, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of hyperphosphataemia, kidney disease and disorders, [ and osteoporosis ]
Owner
- TAKEDA PHARMACEUTICALS U.S.A., INC., Cambridge, MA, US
- Shire International Licensing BV, Amsterdam, NL
- Shire International Licensing BV, NL-1076 EE Amsterdam, NL
- Shire International Licensing BV, NL-1076 EE Amsterdam, NL
Prior registrations
Prosecution history
- 22 Oct 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 22 Oct 2025 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 22 Oct 2025 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 22 Oct 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 02 Jul 2025 — TEAS SECTION 8 & 9 RECEIVED
- 21 Nov 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 21 Nov 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 21 Nov 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 21 Nov 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 21 Nov 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 26 Jul 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 01 Mar 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 02 Jul 2020 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 01 Jul 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 01 Jul 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED